Page last updated: 2024-08-21

2-tert-butylhydroquinone and troglitazone

2-tert-butylhydroquinone has been researched along with troglitazone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auld, DS; Austin, CP; Huang, R; Moeller, TA; Sakamuru, S; Shinn, P; Shukla, SJ; Vanleer, D; Xia, M1
Davies, GF; Eftekharpour, E; Juurlink, BH; Roesler, WJ; Wu, L1

Other Studies

2 other study(ies) available for 2-tert-butylhydroquinone and troglitazone

ArticleYear
Identification of clinically used drugs that activate pregnane X receptors.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:1

    Topics: Animals; Cell Line, Tumor; Cytochrome P-450 CYP3A; Drug Interactions; Hep G2 Cells; Hepatocytes; Humans; Pharmaceutical Preparations; Pregnane X Receptor; Rats; Receptors, Steroid; Small Molecule Libraries; Species Specificity; Structure-Activity Relationship; Xenobiotics

2011
Troglitazone selectively inhibits glyoxalase I gene expression.
    Diabetologia, 2001, Volume: 44, Issue:11

    Topics: Animals; Antioxidants; Astrocytoma; Cell Culture Techniques; Cells, Cultured; Chromans; Gene Expression Regulation, Enzymologic; Glutathione; Hepatocytes; Humans; Hydroquinones; Hypoglycemic Agents; Kinetics; Lactoylglutathione Lyase; Liver; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Thiolester Hydrolases; Time Factors; Troglitazone; Tumor Cells, Cultured

2001